CellSeed Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
CellSeed Inc. made a loss over the last year. CellSeed Inc. owes ¥0.15 for every ¥1 it owns. CellSeed Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
LossCellSeed Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.20The share price is 4.20 times CellSeed Inc.'s book value per share, higher than 85% of Healthcare companies in Japan.
Market cap
¥7.5 BThe total market value of all of CellSeed Inc.'s shares at today's price (share price × number of shares), smaller than 68% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.8 BWhat CellSeed Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥45.00Net worth divided by the number of shares. The share price of ¥189.00 is 4.2 times this, which is the P/B above.
Return on equity (ROE)
-71.7%CellSeed Inc. lost 71.7% of its shareholders' money over the last year, lower than 93% of Healthcare companies in Japan.
Owes vs Owns
0.15×CellSeed Inc. owes ¥0.15 for every ¥1 it owns (low), lower than 85% of Healthcare companies in Japan.
Dividend yield
NoneCellSeed Inc. does not currently pay a dividend.
Revenue growth
-57%Revenue fell 57% in the year to Dec 2025, and shrank 13% a year on average over 3 years.
Profit growth
LossCellSeed Inc. made a loss in each of the last two years.
Profit margin
-1319.5%CellSeed Inc. lost ¥1319 for every ¥100 of revenue.
Interest cover
Not coveredCellSeed Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashCellSeed Inc. held ¥1.2 B more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CellSeed Inc.: ¥7.5 B ÷ ¥1.8 B (30 Jun 2026) = 4.2.
What is CellSeed Inc.'s return on equity?
CellSeed Inc. lost 71.7% of its shareholders' money over the last year, lower than 93% of Healthcare companies in Japan.
How much does CellSeed Inc. owe compared with what it owns?
CellSeed Inc. owes ¥0.15 for every ¥1 it owns (low), lower than 85% of Healthcare companies in Japan.
Does CellSeed Inc. pay a dividend?
No. CellSeed Inc. does not currently pay a dividend.
Is CellSeed Inc.'s revenue growing?
Revenue fell 57% in the year to Dec 2025, and shrank 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.